MEK hyperphosphorylation coincides with cell cycle shut down of cultured smooth muscle cells
- 26 May 2005
- journal article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 206 (1) , 25-34
Abstract
Smooth muscle cells (SMCs) form the backbone of arteries and their proliferation hallmarks collateral vessel growth, a process termed arteriogenesis, as well as pathogenic responses such as restenosis. Since signaling pathways in SMCs are the main targets for therapeutic interventions, we aimed to determine how and to what extent the activation of the ubiquitous MEK–ERK signaling pathway correlates with important in vivo phenomena such as dedifferentiation, nuclear activation and proliferation of SMCs. Specificity of this pathway was monitored using MEK inhibitors UO126 and PD98059 in platelet derived growth factor‐AB (PDGF‐AB)‐ and fibroblast growth factor‐2 (FGF‐2)‐stimulated SMCs. PDGF‐AB induced a rapid MEK activation followed by phosphorylation of the MEK substrates ERK1/2 while FGF‐2 showed a less pronounced and delayed activation. Both growth factors triggered a marked phosphorylation of c‐Myc and expression of Egr1. Pretreatment with MEK inhibitors suppressed the activation of the ERK cascade, abolished the down‐regulation of desmin and led to cell cycle arrest. However, the reversibility of p27Kip1 down‐regulation by UO126 was mainly observed after PDGF‐AB stimulation, indicating MEK independent p27Kip1 down‐regulation by FGF‐2. Surprisingly, treatment of SMCs with UO126 or PD98059 increased the level of MEK phosphorylation in a dose dependent manner at serine residues 217/221 in the presence as well as in the absence of both growth factors. Our results strongly imply that depending on the environmental context phosphorylation of serines 217/221 serves as an “on” as well as an “off ” switch.Keywords
This publication has 34 references indexed in Scilit:
- Involvement of the Fibroblast Growth Factor System in Adaptive and Chemokine-Induced ArteriogenesisCirculation Research, 2003
- Identification of a Novel Mitogen-Activated Protein Kinase Kinase Activation Domain Recognized by the Inhibitor PD 184352Molecular and Cellular Biology, 2002
- Phosphorylation of Raf-1 by Kinase Suppressor of Ras Is Inhibited by “MEK-Specific” Inhibitors PD 098059 and U0126 in Differentiating HL60 CellsExperimental Cell Research, 2001
- Connexin37, not Cx40 and Cx43, is Induced in Vascular Smooth Muscle Cells During Coronary ArteriogenesisJournal of Molecular and Cellular Cardiology, 2001
- Phenotypic modulation of arterial smooth muscle cells is associated with prolonged activation of ERK1/2Differentiation, 2001
- Vascular Remodeling and Altered Protein Expression During Growth of Coronary Collateral ArteriesJournal of Molecular and Cellular Cardiology, 1998
- Enhanced Ribosomal Association of p27Kip1 mRNA Is a Mechanism Contributing to Accumulation during Growth ArrestJournal of Biological Chemistry, 1997
- Integration of MAP Kinase Signal Transduction Pathways at the Serum Response ElementScience, 1995
- Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factorsFEBS Letters, 1994
- Actin isoformsCurrent Opinion in Cell Biology, 1993